Batman: Arkham Shadow dives deeply into Harvey Dent's psyche with a profound backstory that one other antagonist has sadly ...

Batman has been one of the most esteemed and successful superheroes on the big screen in the last two decades or so, but his ...

Investors interested in stocks from the Medical - Biomedical and Genetics sector have probably already heard of Gilead Sciences (GILD) and Vertex Pharmaceuticals (VRTX). But which of these two ...

In the latest market close, Gilead Sciences (GILD) reached $115.99, with a +1.47% movement compared to the previous day. This move outpaced the S&P 500's daily loss of 1.76%. Meanwhile ...

A new Batman Beyond rumor has caught many Batman and DC fans by surprise. Batman Beyond, known as Batman of the Future in Europe, debuted back in 1999 via Paul Dini, Bruce Timm, and Alan Burnett.

As part of the Absolute Universe, the new DC Comics line that reimagines core characters, Absolute Batman frequently wrestles with this question. Creators Scott Snyder and Nick Dragotta recreate ...

Medical pioneer Gilead Sciences GILD has seen its stock etch out new 52-week highs as the broader market pulled back sharply in recent weeks. Gilead has joined Johnson & Johnson JNJ, and a ...

Below is Validea's guru fundamental report for GILEAD SCIENCES INC (GILD). Of the 22 guru strategies we follow, GILD rates highest using our Earnings Yield Investor model based on the published ...

It's hard to believe that Christopher Nolan's Dark Knight trilogy started 20 years ago with 2005’s Batman Begins. The film, starring Christian Bale as The Dark Knight, retold the hero's origin ...

Drug maker Gilead (GILD) is rallying 7.5% after the company reported stronger-than-expected fourth-quarter results and provided 2025 earnings per share guidance that came in above analysts ...

Michileen Martin is a contributing entertainment writer located in New York. His focus is on Comics and Comic Book Movies. He has in-depth knowledge of Comics as a whole, being a fan for over 40 ...